Biotricity, Inc. - Statements of Cash Flows - USD ($)	4 Months Ended	12 Months Ended
	Dec. 31, 2015	Aug. 31, 2015
Cash flow from operating activities:
Net income/(loss)	$ 195,746	$ (90,813)
Adjustments to reconcile net income/(loss) to cash (used in) operating activities:
Debt forgiveness	(254,031)
Change in prepaid expenses and other	5,780	(14,338)
Change in accounts payable	17,852	60,200
Change in accrued compensation and other	11,000	18,000
Net Cash (used in) operating activities	(23,653)	(26,951)
Cash flows from financing activities:
Proceeds from sale of common stock		45,000
Deferred offering costs paid in cash		(27,200)
Loans from unrelated parties	20,357	30,061
Payment of loans to unrelated parties	(1,000)	(16,500)
Net Cash provided by financing activities	19,357	31,361
Change in cash	(4,296)	4,410
Cash, beginning of period	4,410
Cash, end of period	$ 114	$ 4,410
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:
Stock issued for intangible asset